Esther Hulleman Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology Cancer Center Amsterdam Biography Publications Institution JoVE Articles Esther Hulleman has not added a biography. If you are Esther Hulleman and would like to personalize this page please email our Author Liaison for assistance. Publications Development of Transient Radioresistance During Fractionated Irradiation in Vitro Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology. Apr, 2020 | Pubmed ID: 32344261 Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine Glioma Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jul, 2020 | Pubmed ID: 32165429 MEK/MELK Inhibition and Blood-brain Barrier Deficiencies in Atypical Teratoid/rhabdoid Tumors Neuro-oncology. 01, 2020 | Pubmed ID: 31504799 Patient-Derived Orthotopic Xenograft Models of Pediatric Brain Tumors: In a Mature Phase or Still in Its Infancy? Frontiers in Oncology. 2019 | Pubmed ID: 31970083 Celastrol-induced Degradation of FANCD2 Sensitizes Pediatric High-grade Gliomas to the DNA-crosslinking Agent Carboplatin EBioMedicine. Dec, 2019 | Pubmed ID: 31735550 Preclinical Therapeutic Targets in Diffuse Midline Glioma Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 05, 2019 | Pubmed ID: 31202081 An Efficient Method for the Transduction of Primary Pediatric Glioma Neurospheres MethodsX. 2018 | Pubmed ID: 30622915 MELK Inhibition in Diffuse Intrinsic Pontine Glioma Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 11, 2018 | Pubmed ID: 30061363 IL-13 Receptors As Possible Therapeutic Targets in Diffuse Intrinsic Pontine Glioma PloS One. 2018 | Pubmed ID: 29621254 Identification of Two Protein-Signaling States Delineating Transcriptionally Heterogeneous Human Medulloblastoma Cell Reports. 03, 2018 | Pubmed ID: 29562177 Signaling Pathways and Mesenchymal Transition in Pediatric High-grade Glioma Cellular and Molecular Life Sciences : CMLS. Mar, 2018 | Pubmed ID: 29164272 Deceptive Morphologic and Epigenetic Heterogeneity in Diffuse Intrinsic Pontine Glioma Oncotarget. 09, 2017 | Pubmed ID: 28947983 Culture Methods of Diffuse Intrinsic Pontine Glioma Cells Determine Response to Targeted Therapies Experimental Cell Research. 11, 2017 | Pubmed ID: 28947132 Multiregional Tumor Drug-uptake Imaging by PET and Microvascular Morphology in End-stage Diffuse Intrinsic Pontine Glioma Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Aug, 2017 | Pubmed ID: 28818988 A Chemical Screen for Medulloblastoma Identifies Quercetin As a Putative Radiosensitizer Oncotarget. Jun, 2016 | Pubmed ID: 26967057 Functionally Defined Therapeutic Targets in Diffuse Intrinsic Pontine Glioma Nature Medicine. Jun, 2015 | Pubmed ID: 25939062 A Dual Program for Translation Regulation in Cellular Proliferation and Differentiation Cell. Sep, 2014 | Pubmed ID: 25215487 Identification of Temozolomide Resistance Factors in Glioblastoma Via Integrative MiRNA/mRNA Regulatory Network Analysis Scientific Reports. Jun, 2014 | Pubmed ID: 24919120 EFEMP1 Induces γ-secretase/Notch-mediated Temozolomide Resistance in Glioblastoma Oncotarget. Jan, 2014 | Pubmed ID: 24495907 EphB2 Activity Plays a Pivotal Role in Pediatric Medulloblastoma Cell Adhesion and Invasion Neuro-oncology. Sep, 2012 | Pubmed ID: 22723427 EZH2-regulated DAB2IP is a Medulloblastoma Tumor Suppressor and a Positive Marker for Survival Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Aug, 2012 | Pubmed ID: 22696229 PARP Inhibition Sensitizes Childhood High Grade Glioma, Medulloblastoma and Ependymoma to Radiation Oncotarget. Dec, 2011 | Pubmed ID: 22184287 Blood Platelets Contain Tumor-derived RNA Biomarkers Blood. Sep, 2011 | Pubmed ID: 21832279 MiR-101 is Down-regulated in Glioblastoma Resulting in EZH2-induced Proliferation, Migration, and Angiogenesis Oncotarget. Dec, 2010 | Pubmed ID: 21321380 Ein hochdurchsatzgesteuertes, stereotaktisches Neuronavigations- und fokussiertes Ultraschallsystem für die Öffnung der Blut-Hirn-Barriere bei Nagetieren Rianne Haumann*1,2, Elvin ’t Hart*2, Marc P. P. Derieppe2, Helena C. Besse3, Gertjan J. L. Kaspers1,2, Eelco Hoving2, Dannis G. van Vuurden1,2, Esther Hulleman1,2, Mario Ries3 1Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, Cancer Center Amsterdam, 2Princess Máxima Center for Pediatric Oncology, 3Imaging Division, Utrecht University JoVE 61269 Neuroscience
Ein hochdurchsatzgesteuertes, stereotaktisches Neuronavigations- und fokussiertes Ultraschallsystem für die Öffnung der Blut-Hirn-Barriere bei Nagetieren Rianne Haumann*1,2, Elvin ’t Hart*2, Marc P. P. Derieppe2, Helena C. Besse3, Gertjan J. L. Kaspers1,2, Eelco Hoving2, Dannis G. van Vuurden1,2, Esther Hulleman1,2, Mario Ries3 1Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, Cancer Center Amsterdam, 2Princess Máxima Center for Pediatric Oncology, 3Imaging Division, Utrecht University JoVE 61269 Neuroscience
